Levy R - Search Results

1

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Vogel Z, et al. Among authors: levy r. J Neurochem. 1993 Jul;61(1):352-5. doi: 10.1111/j.1471-4159.1993.tb03576.x. J Neurochem. 1993. PMID: 8515284

2

Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides.

Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z. Barg J, et al. Among authors: levy r. Eur J Pharmacol. 1995 Dec 12;287(2):145-52. doi: 10.1016/0014-2999(95)00487-4. Eur J Pharmacol. 1995. PMID: 8749028

3

Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.

Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L, Breuer A, Mechoulam R. Rhee MH, et al. Among authors: levy r. J Med Chem. 1997 Sep 26;40(20):3228-33. doi: 10.1021/jm970126f. J Med Chem. 1997. PMID: 9379442

4

Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.

Rhee MH, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z. Rhee MH, et al. Among authors: levy r. J Neurochem. 1998 Oct;71(4):1525-34. doi: 10.1046/j.1471-4159.1998.71041525.x. J Neurochem. 1998. PMID: 9751186 Free article.

5

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling.

Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z. Bayewitch M, et al. Among authors: levy r. FEBS Lett. 1995 Nov 13;375(1-2):143-7. doi: 10.1016/0014-5793(95)01207-u. FEBS Lett. 1995. PMID: 7498464 Free article.

6

Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.

Fride E, Barg J, Levy R, Saya D, Heldman E, Mechoulam R, Vogel Z. Fride E, et al. Among authors: levy r. J Pharmacol Exp Ther. 1995 Feb;272(2):699-707. J Pharmacol Exp Ther. 1995. PMID: 7853184

7

kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.

Avidor-Reiss T, Zippel R, Levy R, Saya D, Ezra V, Barg J, Matus-Leibovitch N, Vogel Z. Avidor-Reiss T, et al. Among authors: levy r. FEBS Lett. 1995 Mar 13;361(1):70-4. doi: 10.1016/0014-5793(95)00154-2. FEBS Lett. 1995. PMID: 7890042 Free article.

8

Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells.

Barg J, Belcheva MM, Zimlichman R, Levy R, Saya D, McHale RJ, Johnson FE, Coscia CJ, Vogel Z. Barg J, et al. Among authors: levy r. J Neurosci. 1994 Oct;14(10):5858-64. doi: 10.1523/JNEUROSCI.14-10-05858.1994. J Neurosci. 1994. PMID: 7931548 Free PMC article.

9

Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures.

Barg J, Nah SY, Levy R, Saya D, Vogel Z. Barg J, et al. Among authors: levy r. Brain Res. 1993 Nov 26;629(1):109-14. doi: 10.1016/0006-8993(93)90488-9. Brain Res. 1993. PMID: 8287265

10

A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA.

Barg J, Belcheva MM, Levy R, McHale RJ, McLachlan JA, Johnson FE, Coscia CJ, Vogel Z. Barg J, et al. Among authors: levy r. Glia. 1994 Jan;10(1):10-5. doi: 10.1002/glia.440100103. Glia. 1994. PMID: 8300189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,961 results

Search Page

Filters